Jennifer Doudna and Emmanuelle Charpentier received the 2020 Nobel Prize in Chemistry for creating a world-changing gene-editing technology. At the ALS, Doudna’s work on CRISPR-Cas9 was enabled by many people with innovative ideas, implemented in support of a world-class structural biology program. https://als.lbl.gov/jennifer-doudna-and-the-nobel-prize-the-advanced-light-source-perspective/
January 2019 – July 2022
